Clostridioides difficile infection (CDI) remains a major healthcare problem worldwide, however, little is known about CDI epidemiology in Iran. Between December 2004 and November 2018, 3649 stool samples were collected from patients in 69 hospitals and medical centres in Tehran and were cultured for the presence of C. difficile; isolates were characterized by PCR ribotyping and toxin genes detection. A total of 582 C. difficile isolates were obtained and the overall CDI prevalence was 15.9%; 290 (49.8%) cases were healthcare-associated (HA) and 292 (50.2%) cases were community-associated (CA). Of these, DNA of 513 isolates submitted for ribotyping. The ribotype and/or WEBRIBO type could be assessed in 366 (62.9%) isolates. The most frequent RTs were 001 (n = 75, 12.9%), 126 (n = 65, 11.2%) and 084 (n = 19, 3.3%); the toxin gene profile tcdA + B + /cdtA + B + (n = 112, 19.2%) was the most common. Fifteen C. difficile isolates (2.6%) did not carry any toxin genes. There was no difference between frequently found RTs in HA-CDI and CA-CDI, except for RT 029 which was more likely to be associated with healthcare origin (12/15, p-value = 0.02). No isolate of RTs 027 or 078 was identified. Importantly, RTs 031, 038, 039, 084, 085 reported previously as RTs with an absence of toxin genes, revealed the presence of toxin genes in our study. Using Simpson's reciprocal index of diversity, we found that RT diversity decreased as the prevalence of the RT 084 increased (R = -0.78, p-value = 0.041). Different patterns in CDI epidemiology underscore the importance of local surveillance and infection control measures in Tehran healthcare settings.

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center Research Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran

Department of Medical Microbiology Charles University 2nd Faculty of Medicine and Motol University Hospital Prague Czech Republic

European Society of Clinical Microbiology and Infectious Diseases

Foodborne and Waterborne Diseases Research Center Research Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran

Gastroenterology and Liver Diseases Research Center Research Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran

Healthcare Associated Infections Research Group Leeds Teaching Hospitals NHS Trust and University of Leeds Leeds UK

Zobrazit více v PubMed

Martin JS, Monaghan TM, Wilcox MH.. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastro Hepat. 2016;13(4):206–216. PubMed

Schaeffler H, Breitrueck A.. Clostridium difficile–from colonization to infection. Front Microbiol. 2018;9:646. PubMed PMC

Carey-Ann BD, Carroll KC.. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev. 2013;26(3):604–630. PubMed PMC

Kato H, Kato N, Watanabe K, et al. . Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol. 1998;36(8):2178–2182. PubMed PMC

Guery B, Galperine T, Barbut F.. Clostridioides difficile: diagnosis and treatments. BMJ. 2019;366:l4609. PubMed

Crobach M, Planche T, Eckert C, et al. . European society of clinical microbiology and infectious diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016;22:S63–S81. PubMed

Eyre DW, Griffiths D, Vaughan A, et al. . Asymptomatic Clostridium difficile colonisation and onward transmission. PloS One. 2013;8(11). PubMed PMC

Dubberke ER, Reske KA, Seiler S, et al. . Risk factors for acquisition and loss of Clostridium difficile colonization in hospitalized patients. Antimicrob Agents Chemother. 2015;59(8):4533–4543. PubMed PMC

Fuereder T, Koni D, Gleiss A, et al. . Risk factors for Clostridium difficile infection in hemato-oncological patients: a case control study in 144 patients. Sci Rep. 2016;6(1):1–8. PubMed PMC

Rodríguez-Pardo D, Almirante B, Bartolomé RM, et al. . Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J Clin Microbiol. 2013;51(5):1465–1473. PubMed PMC

Sheitoyan-Pesant C, Abou Chakra CN, Pépin J, et al. . Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection. Clin Infect Dis. 2016;62(5):574–580. PubMed

McDonald LC, Gerding DN, Johnson S, et al. . Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and society for healthcare epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48. PubMed PMC

Walker AS, Eyre DW, Wyllie DH, et al. . Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis. 2013;56(11):1589–1600. PubMed PMC

Loo VG, Bourgault A-M, Poirier L, et al. . Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693–1703. PubMed

Knight DR, Elliott B, Chang BJ, et al. . Diversity and evolution in the genome of Clostridium difficile. Clin Microbiol Rev. 2015;28(3):721–741. PubMed PMC

Kuijper E, Coignard B, Tüll P, et al. . Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12:2–18. PubMed

He M, Miyajima F, Roberts P, et al. . Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2013;45(1):109–113. PubMed PMC

Fawley WN, Knetsch C, MacCannell DR, et al. . Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile. PloS One. 2015;10(2):e0118150. PubMed PMC

Krutova M, Kinross P, Barbut F, et al. . How to: surveillance of Clostridium difficile infections. Clin Microbiol Infect. 2018;24(5):469–475. PubMed

Aliramezani A, Talebi M, Golbabaei F, et al. . Characterization of Clostridioides difficile isolates recovered from hospitalized patients and the hospitals environment and air: a multicenter study. Anaerobe. 2019;59:154–158. PubMed

Khoshdel A, Habibian R, Parvin N, et al. . Molecular characterization of nosocomial Clostridium difficile infection in pediatric ward in Iran. SpringerPlus. 2015;4(1):627. PubMed PMC

Kouhsari E, Douraghi M, Krutova M, et al. . The emergence of metronidazole and vancomycin reduced susceptibility in Clostridium difficile isolates in Iran. J Glob Antimicrob Resist. 2019;18:28–33. PubMed

Thornton CS, Rubin JE, Greninger AL, et al. . Epidemiological and genomic characterization of community-acquired Clostridium difficile infections. BMC Infect Dis. 2018;18(1):1–9. PubMed PMC

Persson S, Torpdahl M, Olsen K.. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect. 2008;14(11):1057–1064. PubMed

Azimirad M, Krutova M, Balaii H, et al. . Coexistence of Clostridioides difficile and Staphylococcus aureus in gut of Iranian outpatients with underlying inflammatory bowel disease. Anaerobe. 2020;61:102113. PubMed

Cohen SH, Tang YJ, Silva J. Jr. Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis. 2000;181(2):659–663. PubMed

Indra A, Huhulescu S, Schneeweis M, et al. . Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol. 2008;57(Pt 11):1377–1382. PubMed PMC

Bauer MP, Notermans DW, Van Benthem BH, et al. . Clostridium difficile infection in Europe: a hospital-based survey. The Lancet. 2011;377(9759):63–73. PubMed

DePestel DD, Aronoff DM.. Epidemiology of Clostridium difficile infection. J Pharm Pract. 2013;26(5):464–475. PubMed PMC

Freeman J, Bauer M, Baines SD, et al. . The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529–549. PubMed PMC

Jalali M, Khorvash F, Warriner K, et al. . Clostridium difficile infection in an Iranian hospital. BMC Res Notes. 2012;5(1):159. PubMed PMC

Shoaei P, Shojaei H, Khorvash F, et al. . Molecular epidemiology of Clostridium difficile infection in Iranian hospitals. Antimicrob Resist Infect Contr. 2019;8(1):12. PubMed PMC

Zarandi ER, Mansouri S, Nakhaee N, et al. . Frequency of antibiotic associated diarrhea caused by Clostridium difficile among hospitalized patients in intensive care unit, Kerman, Iran. Gastroenterol Hepatol Bed Bench. 2017;10(3):229. PubMed PMC

Farshad S, Azami M, Pouladfar G, et al. . Prevalence and risk factors of Clostridium difficile-associated diarrhea in Iranian hospitalized patients. Ann Trop Med Public Heal. 2013;6(5):554.

Lessa FC, Mu Y, Bamberg WM, et al. . Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–834. PubMed PMC

Jamal W, Rotimi V, Brazier J, et al. . Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period. Anaerobe. 2010;16(6):560–565. PubMed

Al-Thani AA, Hamdi WS, Al-Ansari NA, et al. . Erratum: polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study. BMC Infect Dis. 2015;15(1):173. PubMed PMC

Azimirad M, Dezfulian A, Alebouyeh M, et al. . Infection with enterotoxigenic Staphylococcus aureus as a concern in patients with gastroenteritis. J Glob Antimicrob Resist. 2017;9:111–114. PubMed

Kouhsari E, Douraghi M, Fakhre Yaseri H, et al. . Molecular typing of Clostridioides difficile isolates from clinical and non-clinical samples in Iran. Apmis. 2019;127(4):222–227. PubMed

Heidari H, Sedigh Ebrahim-Saraie H, Amanati A, et al. . Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile. Iran J Basic Med Sci. 2019;22(7):813–819. PubMed PMC

Rotimi V, Jamal WY, Mokaddas EM, et al. . Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait. J Med Microbiol. 2003;52(8):705–709. PubMed

Jamal WY, Rotimi VO.. Surveillance of antibiotic resistance among hospital-and community-acquired toxigenic Clostridium difficile isolates over 5-year period in Kuwait. PloS One. 2016;11(8):e0161411. PubMed PMC

Berger FK, Rasheed SS, Araj GF, et al. . Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. Int J Med Microbiol. 2018;308(3):358–363. PubMed

Adler A, Miller-Roll T, Bradenstein R, et al. . A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole. Diagn Microbiol Infect Dis. 2015;83(1):21–24. PubMed

Janssen I, Cooper P, Gunka K, et al. . High prevalence of nontoxigenic Clostridium difficile isolated from hospitalized and non-hospitalized individuals in rural Ghana. Int J Med Microbiol. 2016;306(8):652–656. PubMed

Djebbar A, Sebaihia M, Kuijper E, et al. . First molecular characterisation and PCR ribotyping of Clostridium difficile strains isolated in two Algerian hospitals. J Infect Dev Countr. 2018;12(01):015–021. PubMed

Seugendo M, Janssen I, Lang V, et al. . Prevalence and strain characterization of Clostridioides (Clostridium) difficile in representative regions of Germany, Ghana, Tanzania and Indonesia–a comparative multi-center cross-sectional study. Front Microbiol. 2018;9:1843. PubMed PMC

Davies KA, Ashwin H, Longshaw CM, et al. . Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Eurosurveillance. 2016;21(29):30294. PubMed

Riley TV, Collins DA, Karunakaran R, et al. . High prevalence of toxigenic and nontoxigenic Clostridium difficile strains in Malaysia. J Clin Microbiol. 2018;56(6):e00170–18. PubMed PMC

Collins D, Gasem M, Habibie T, et al. . Prevalence and molecular epidemiology of Clostridium difficile infection in Indonesia. New Microbes New Infect. 2017;18:34–37. PubMed PMC

Putsathit P, Maneerattanaporn M, Piewngam P, et al. . Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand. New Microbes New Infect. 2017;15:27–32. PubMed PMC

Zidaric V, Beigot S, Lapajne S, et al. . The occurrence and high diversity of Clostridium difficile genotypes in rivers. Anaerobe. 2010;16(4):371–375. PubMed

Dingle KE, Elliott B, Robinson E, et al. . Evolutionary history of the Clostridium difficile pathogenicity locus. Genome Biol Evol. 2014;6(1):36–52. PubMed PMC

Guh AY, Adkins SH, Li Q, et al. , editors. Risk factors for community-associated Clostridium difficile infection in adults: a case-control study. Open Forum Infect Dis. 2017;4(4):ofx171. PubMed PMC

Slimings C, Riley TV.. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881–891. PubMed

Tay H, Chow A, Ng T, et al. . Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore. Sci Rep. 2019;9(1):1–7. PubMed PMC

Hunter JC, Mu Y, Dumyati GK, et al. , editors. Burden of nursing home-onset Clostridium difficile infection in the United States: estimates of incidence and patient outcomes. Open Forum Infect Dis. 2016;3(1):ofv196. PubMed PMC

Noori M, Yadegar A, Zali MR.. A complex scenario of nonsteroidal anti-inflammatory drugs induced prostaglandin E2 production and gut microbiota alteration in Clostridium difficile-infected mice. mBio. 2020;11(1):e02596–19. PubMed PMC

Goorhuis A, Van der Kooi T, Vaessen N, et al. . Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis. 2007;45(6):695–703. PubMed

Sundram F, Guyot A, Carboo I, et al. . Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. J Hosp Infect. 2009;72(2):111–118. PubMed